Accelerate Diagnostics, Inc. (AXDX)
USD 0.64
(-7.51%)
USD 0.64
(-7.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 27.08 Million USD | -36.48% |
| 2022 | 42.63 Million USD | -40.13% |
| 2021 | 71.21 Million USD | -37.64% |
| 2020 | 114.2 Million USD | 56.32% |
| 2019 | 73.05 Million USD | 35.76% |
| 2018 | 53.81 Million USD | 288.73% |
| 2017 | -28.51 Million USD | -48.17% |
| 2016 | -19.24 Million USD | 84.04% |
| 2015 | -120.57 Million USD | -125.78% |
| 2014 | -53.4 Million USD | -77.84% |
| 2013 | -30.02 Million USD | -110.53% |
| 2012 | -14.26 Million USD | -1738.39% |
| 2011 | -775.85 Thousand USD | -173.89% |
| 2010 | -283.27 Thousand USD | 67.14% |
| 2009 | -862.07 Thousand USD | 30.09% |
| 2008 | -1.23 Million USD | 11.52% |
| 2007 | -1.39 Million USD | 53.61% |
| 2006 | -3 Million USD | 46.01% |
| 2005 | -5.56 Million USD | 23.08% |
| 2004 | -7.23 Million USD | 16.97% |
| 2003 | -8.71 Million USD | -0.94% |
| 2002 | -8.63 Million USD | 9.36% |
| 2001 | -9.52 Million USD | 8.08% |
| 2000 | -10.35 Million USD | -1.0% |
| 1999 | -10.25 Million USD | 1.74% |
| 1998 | -10.43 Million USD | -32.14% |
| 1997 | -7.9 Million USD | -464.29% |
| 1996 | -1.4 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 33.82 Million USD | 31.05% |
| 2024 Q1 | 25.8 Million USD | -4.7% |
| 2023 FY | 27.08 Million USD | -36.48% |
| 2023 Q1 | 48.62 Million USD | 14.05% |
| 2023 Q2 | 7.28 Million USD | -85.01% |
| 2023 Q4 | 27.08 Million USD | 65.05% |
| 2023 Q3 | 16.4 Million USD | 125.14% |
| 2022 Q1 | 105.31 Million USD | 47.88% |
| 2022 FY | 42.63 Million USD | -40.13% |
| 2022 Q4 | 42.63 Million USD | 12.44% |
| 2022 Q3 | 37.91 Million USD | -64.36% |
| 2022 Q2 | 106.39 Million USD | 1.02% |
| 2021 Q3 | 77.99 Million USD | -29.94% |
| 2021 Q4 | 71.21 Million USD | -8.69% |
| 2021 FY | 71.21 Million USD | -37.64% |
| 2021 Q1 | 110.16 Million USD | -3.53% |
| 2021 Q2 | 111.32 Million USD | 1.05% |
| 2020 Q3 | 120.52 Million USD | 24.63% |
| 2020 Q4 | 114.2 Million USD | -5.24% |
| 2020 Q1 | 97.14 Million USD | 32.98% |
| 2020 FY | 114.2 Million USD | 56.32% |
| 2020 Q2 | 96.7 Million USD | -0.46% |
| 2019 Q2 | 37.82 Million USD | -20.6% |
| 2019 Q3 | 38.38 Million USD | 1.49% |
| 2019 FY | 73.05 Million USD | 35.76% |
| 2019 Q4 | 73.05 Million USD | 90.33% |
| 2019 Q1 | 47.63 Million USD | -11.47% |
| 2018 Q1 | -27.68 Million USD | 2.9% |
| 2018 FY | 53.81 Million USD | 288.73% |
| 2018 Q4 | 53.81 Million USD | -4.13% |
| 2018 Q3 | 56.13 Million USD | 15.29% |
| 2018 Q2 | 48.68 Million USD | 275.87% |
| 2017 Q1 | -9.91 Million USD | 48.47% |
| 2017 Q3 | -34.43 Million USD | 45.01% |
| 2017 Q4 | -28.51 Million USD | 17.19% |
| 2017 FY | -28.51 Million USD | -48.17% |
| 2017 Q2 | -62.6 Million USD | -531.33% |
| 2016 Q2 | -37.51 Million USD | 47.91% |
| 2016 Q4 | -19.24 Million USD | 33.02% |
| 2016 Q3 | -28.73 Million USD | 23.42% |
| 2016 FY | -19.24 Million USD | 84.04% |
| 2016 Q1 | -72.03 Million USD | 40.26% |
| 2015 Q2 | -35.14 Million USD | 25.65% |
| 2015 Q1 | -47.26 Million USD | 11.49% |
| 2015 Q4 | -120.57 Million USD | -379.58% |
| 2015 FY | -120.57 Million USD | -125.78% |
| 2015 Q3 | -25.14 Million USD | 28.46% |
| 2014 FY | -53.4 Million USD | -77.84% |
| 2014 Q1 | -25.87 Million USD | 13.83% |
| 2014 Q3 | -57.65 Million USD | 11.27% |
| 2014 Q4 | -53.4 Million USD | 7.37% |
| 2014 Q2 | -64.98 Million USD | -151.13% |
| 2013 Q2 | -27.17 Million USD | 7.12% |
| 2013 Q3 | -33.45 Million USD | -23.11% |
| 2013 Q4 | -30.02 Million USD | 10.24% |
| 2013 FY | -30.02 Million USD | -110.53% |
| 2013 Q1 | -29.25 Million USD | -142.42% |
| 2012 Q1 | -212.99 Thousand USD | 58.48% |
| 2012 Q2 | -14.26 Million USD | -6596.52% |
| 2012 Q3 | -13.19 Million USD | 7.48% |
| 2012 Q4 | -12.06 Million USD | 8.54% |
| 2012 FY | -14.26 Million USD | -1738.39% |
| 2011 Q2 | -775.85 Thousand USD | -108.42% |
| 2011 FY | -775.85 Thousand USD | -173.89% |
| 2011 Q1 | -372.26 Thousand USD | 12.46% |
| 2011 Q3 | -584.98 Thousand USD | 24.6% |
| 2011 Q4 | -513.02 Thousand USD | 12.3% |
| 2010 Q1 | -166.11 Thousand USD | -52.6% |
| 2010 FY | -283.27 Thousand USD | 67.14% |
| 2010 Q4 | -425.26 Thousand USD | -91.14% |
| 2010 Q3 | -222.49 Thousand USD | 21.46% |
| 2010 Q2 | -283.27 Thousand USD | -70.53% |
| 2009 Q3 | -470.46 Thousand USD | 45.43% |
| 2009 FY | -862.07 Thousand USD | 30.09% |
| 2009 Q1 | -978.9 Thousand USD | 0.81% |
| 2009 Q2 | -862.07 Thousand USD | 11.93% |
| 2009 Q4 | -108.86 Thousand USD | 76.86% |
| 2008 Q4 | -986.85 Thousand USD | 8.74% |
| 2008 Q3 | -1.08 Million USD | 12.3% |
| 2008 Q1 | -1.27 Million USD | -45.31% |
| 2008 Q2 | -1.23 Million USD | 3.42% |
| 2008 FY | -1.23 Million USD | 11.52% |
| 2007 Q4 | -878.61 Thousand USD | 14.46% |
| 2007 Q2 | -1.39 Million USD | 22.63% |
| 2007 Q3 | -1.02 Million USD | 26.3% |
| 2007 Q1 | -1.8 Million USD | 14.3% |
| 2007 FY | -1.39 Million USD | 53.61% |
| 2006 Q4 | -2.1 Million USD | 17.14% |
| 2006 FY | -3 Million USD | 46.01% |
| 2006 Q3 | -2.53 Million USD | 15.57% |
| 2006 Q2 | -3 Million USD | 14.57% |
| 2006 Q1 | -3.51 Million USD | 15.94% |
| 2005 Q3 | -4.92 Million USD | 11.54% |
| 2005 Q4 | -4.18 Million USD | 15.0% |
| 2005 Q1 | -5.89 Million USD | 8.18% |
| 2005 FY | -5.56 Million USD | 23.08% |
| 2005 Q2 | -5.56 Million USD | 5.66% |
| 2004 Q1 | -7.51 Million USD | 3.75% |
| 2004 FY | -7.23 Million USD | 16.97% |
| 2004 Q4 | -6.42 Million USD | 5.74% |
| 2004 Q2 | -7.23 Million USD | 3.69% |
| 2004 Q3 | -6.81 Million USD | 5.78% |
| 2003 Q4 | -7.8 Million USD | 4.51% |
| 2003 FY | -8.71 Million USD | -0.94% |
| 2003 Q3 | -8.17 Million USD | 6.2% |
| 2003 Q2 | -8.71 Million USD | -0.24% |
| 2003 Q1 | -8.69 Million USD | 5.3% |
| 2002 Q4 | -9.17 Million USD | -6.19% |
| 2002 FY | -8.63 Million USD | 9.36% |
| 2002 Q1 | -8.6 Million USD | 0.99% |
| 2002 Q2 | -8.63 Million USD | -0.29% |
| 2002 Q3 | -8.64 Million USD | -0.12% |
| 2001 Q2 | -9.52 Million USD | 2.81% |
| 2001 Q4 | -8.69 Million USD | 4.42% |
| 2001 FY | -9.52 Million USD | 8.08% |
| 2001 Q3 | -9.09 Million USD | 4.49% |
| 2001 Q1 | -9.79 Million USD | 2.23% |
| 2000 FY | -10.35 Million USD | -1.0% |
| 2000 Q4 | -10.02 Million USD | 3.27% |
| 2000 Q3 | -10.35 Million USD | 0.0% |
| 2000 Q2 | -10.35 Million USD | -0.47% |
| 2000 Q1 | -10.31 Million USD | 2.37% |
| 1999 FY | -10.25 Million USD | 1.74% |
| 1999 Q1 | -10.29 Million USD | -1.23% |
| 1999 Q2 | -10.25 Million USD | 0.34% |
| 1999 Q3 | -10.55 Million USD | -2.94% |
| 1999 Q4 | -10.56 Million USD | -0.03% |
| 1998 Q2 | -10.43 Million USD | -1.52% |
| 1998 Q1 | -10.28 Million USD | -10.74% |
| 1998 Q3 | -10.58 Million USD | -1.41% |
| 1998 Q4 | -10.16 Million USD | 3.96% |
| 1998 FY | -10.43 Million USD | -32.14% |
| 1997 Q3 | -8.14 Million USD | -3.13% |
| 1997 Q2 | -7.9 Million USD | 0.0% |
| 1997 Q1 | -7.9 Million USD | 1.25% |
| 1997 FY | -7.9 Million USD | -464.29% |
| 1997 Q4 | -9.28 Million USD | -13.97% |
| 1996 Q4 | -8 Million USD | -370.59% |
| 1996 Q1 | -1.1 Million USD | -22.22% |
| 1996 FY | -1.4 Million USD | 0.0% |
| 1996 Q2 | -1.4 Million USD | -27.27% |
| 1996 Q3 | -1.7 Million USD | -21.43% |
| 1995 Q4 | -900 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BrainsWay Ltd. | -10.32 Million USD | 362.422% |
| Cerus Corporation | 84.35 Million USD | 67.894% |
| Envoy Medical, Inc. | -3.81 Million USD | 810.068% |
| electroCore, Inc. | -9.95 Million USD | 372.044% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 628.429% |
| IceCure Medical Ltd | -9.93 Million USD | 372.619% |
| Inogen, Inc. | -103.56 Million USD | 126.149% |
| OrthoPediatrics Corp. | -9.26 Million USD | 392.241% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 843.807% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 306.78% |
| MaxCyte, Inc. | -27.76 Million USD | 197.547% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 627.083% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 4803.639% |
| Orthofix Medical Inc. | 96.44 Million USD | 71.919% |
| PAVmed Inc | 29.08 Million USD | 6.89% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 259.88% |
| RxSight, Inc. | -6.68 Million USD | 505.419% |
| Sight Sciences, Inc. | -102.71 Million USD | 126.366% |
| SI-BONE, Inc. | 5.72 Million USD | -373.379% |
| TELA Bio, Inc. | -3.94 Million USD | 785.794% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 52.754% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -7593.75% |
| Acutus Medical, Inc. | 12.27 Million USD | -120.555% |
| Talis Biomedical Corporation | -57.06 Million USD | 147.459% |
| Spectral AI, Inc. | -3.5 Million USD | 873.55% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 156.389% |
| CVRx, Inc. | -59.95 Million USD | 145.17% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -1264.92% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -2019.694% |
| Bioventus Inc. | 372.51 Million USD | 92.73% |
| Venus Concept Inc. | 74.3 Million USD | 63.551% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 365.979% |
| LivaNova PLC | 62.53 Million USD | 56.691% |
| 908 Devices Inc. | -115.09 Million USD | 123.53% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 91.556% |
| Nemaura Medical Inc. | 9.92 Million USD | -172.866% |
| NeuroPace, Inc. | 54.33 Million USD | 50.159% |
| LENSAR, Inc. | -18.31 Million USD | 247.892% |
| Apyx Medical Corporation | -5.15 Million USD | 625.762% |
| Cutera, Inc. | 288.3 Million USD | 90.606% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -260.373% |
| BioSig Technologies, Inc. | 262 Thousand USD | -10236.641% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 161.789% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 394.402% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 98.073% |
| Axonics, Inc. | -77.19 Million USD | 135.083% |
| Outset Medical, Inc. | 67.67 Million USD | 59.985% |
| IRIDEX Corporation | -4.28 Million USD | 731.576% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 115.213% |
| IRadimed Corporation | -47.71 Million USD | 156.753% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 994.977% |
| INVO Bioscience, Inc. | 8.45 Million USD | -220.454% |
| Telesis Bio, Inc. | 32.63 Million USD | 17.015% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 1182.357% |
| Varex Imaging Corporation | 316.9 Million USD | 91.454% |
| Quipt Home Medical Corp. | 81.73 Million USD | 66.866% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 1073.472% |
| Pulmonx Corporation | -42.36 Million USD | 163.933% |
| Dynatronics Corporation | 6.2 Million USD | -336.523% |
| Modular Medical, Inc. | -8.04 Million USD | 436.757% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 730.254% |
| Semler Scientific, Inc. | -57.13 Million USD | 147.404% |
| InMode Ltd. | -135.39 Million USD | 120.002% |
| Bruker Corporation | 891.3 Million USD | 96.962% |
| Cytosorbents Corporation | 4.18 Million USD | -547.583% |
| DexCom, Inc. | 2.02 Billion USD | 98.664% |
| Align Technology, Inc. | -840.47 Million USD | 103.222% |
| Viveve Medical, Inc. | -13.81 Million USD | 296.062% |
| ZimVie Inc. | 450.41 Million USD | 93.987% |
| Movano Inc. | -5.86 Million USD | 561.677% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 120.142% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 4803.639% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -1264.92% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 92.41% |
| Profound Medical Corp. | -18.17 Million USD | 248.978% |
| Insulet Corporation | 798.1 Million USD | 96.607% |
| enVVeno Medical Corporation | -2.21 Million USD | 1321.01% |
| Surmodics, Inc. | -12.01 Million USD | 325.42% |
| iCAD, Inc. | -21.2 Million USD | 227.691% |
| Nuwellis, Inc. | -2.81 Million USD | 1060.695% |
| Biotricity, Inc. | 23.09 Million USD | -17.275% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 71.082% |
| Aethlon Medical, Inc. | -4.5 Million USD | 701.6% |
| InspireMD, Inc. | -8.04 Million USD | 436.631% |
| PAVmed Inc. | 29.08 Million USD | 6.89% |
| BIOLASE, Inc. | 11.34 Million USD | -138.734% |
| Beyond Air, Inc. | 6.22 Million USD | -334.773% |
| FONAR Corporation | -14.66 Million USD | 284.667% |
| AxoGen, Inc. | 32.26 Million USD | 16.066% |
| Vivani Medical, Inc. | 42 Thousand USD | -64380.952% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 354.1% |
| Inari Medical, Inc. | -7.16 Million USD | 478.187% |
| UFP Technologies, Inc. | 40.77 Million USD | 33.58% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -782.545% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 667.601% |
| Tenon Medical, Inc. | -1.25 Million USD | 2257.928% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 456.061% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 327.078% |
| AdaptHealth Corp. | 2.21 Billion USD | 98.779% |
| Sintx Technologies, Inc. | 905 Thousand USD | -2892.486% |
| NanoVibronix, Inc. | -3.27 Million USD | 926.174% |
| Quanterix Corporation | -132.95 Million USD | 120.369% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 1073.472% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 221.091% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 96.407% |
| TransMedics Group, Inc. | 121.13 Million USD | 77.643% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 203.445% |
| NeuroMetrix, Inc. | -1.49 Million USD | 1916.28% |
| Hyperfine, Inc. | -75.61 Million USD | 135.814% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 82.205% |
| Biomerica, Inc. | -3.38 Million USD | 900.059% |
| Bone Biologics Corporation | -3.02 Million USD | 994.809% |
| AVITA Medical, Inc. | -26.23 Million USD | 203.242% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 1573.12% |
| Silk Road Medical, Inc | 64.42 Million USD | 57.962% |